Mylan, the drug firm that created outrage with the dramatic worth improve of the EpiPen, is on the defensive once more. A brand new report exhibits an enormous rise in complaints in regards to the gadget not working in life-threatening emergencies.
Bloomberg says 228 folks this yr reported failures of EpiPen, which injects a drug that may cease extreme allergic reactions. That is method up from 2012, when simply 4 failures have been reported.
Mylan would not take difficulty with the info however mentioned Bloomberg’s article is “deceptive.” It mentioned an increase in experiences of failures would not essentially imply an increase in precise failures and suggests heightened consideration on the corporate and elevated prescriptions could possibly be responsible, experiences CBS Information correspondent Tony Dokoupil.
However for many who rely on the gadget, any failure is unacceptable.
“Watching your baby sit there scream to you ‘do not let me die’ is terrible for any mother or father to need to undergo,” mentioned Tina Hampton, who has a 6-year-old daughter.
This previous spring, her daughter was gasping for breath after an allergic response to peanuts. Hampton’s second of panic was made worse after she reached for an EpiPen. “After I pulled it out, the needle didn’t return inside the EpiPen, It was bent,” Hampton mentioned.
It sliced her daughter’s leg leaving a scar. She credit a backup EpiPen for saving her kid’s life. Bloomberg obtained knowledge from the FDA, linking 228 experiences of EpiPen failures to seven deaths and 35 hospitalizations this yr. The FDA cautions that with its reporting system, “there isn’t a certainty that the reported occasion … was as a result of product.”
Dr. Scott Sicherer of Mount Sinai Hospital in New York is a pediatric allergy skilled.
“It is a very simple gadget to make use of, however somebody in a panic would possibly use it mistaken,” Sicherer mentioned of the EpiPen.
He confirmed us how shortly the EpiPen deploys. Sluggish-motion provides a greater take a look at the way it delivers a dose of epinepherine – only one shot per gadget. In emergencies, he says some of us mess up holding it the mistaken method.”After they press it, they then get the medicine into their thumb,” Sicherer mentioned.
Regardless of the rise in experiences of failures since 2012, Mylan mentioned “no adjustments have been made to the EpiPen gadget since 2009.” The corporate mentioned they have not discovered a “causal connection” between reported affected person deaths and the EpiPen.
There was a recall of some EpiPens earlier this yr resulting from a faulty half. However the FDA advised CBS Information: “We aren’t conscious of faulty EpiPens presently in the marketplace and suggest that customers use their prescribed epinephrine auto injector.” As for Hampton, whose EpiPen needle lower her daughter, she’s now switched to a competing injector.
© 2017 CBS Interactive Inc. All Rights Reserved.